CN1272060C - Medicine for preventing apoplexy and its preparation method - Google Patents
Medicine for preventing apoplexy and its preparation method Download PDFInfo
- Publication number
- CN1272060C CN1272060C CN 200410012157 CN200410012157A CN1272060C CN 1272060 C CN1272060 C CN 1272060C CN 200410012157 CN200410012157 CN 200410012157 CN 200410012157 A CN200410012157 A CN 200410012157A CN 1272060 C CN1272060 C CN 1272060C
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- medicine
- kilograms
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a medicine for preventing apoplexy, which belongs to a Chinese patent medicine made of Chinese herbal medicines as raw materials. The present invention also relates to a preparation method of the Chinese patent medicine. The medicine for preventing apoplexy mainly solves the technical problems of delay prevention and cure, high therapy cost, etc. existing in the existing medicine for treating apoplexy. The medicine of the present invention is composed of raw materials of the following proportion by weight: 12 to 18 g of unprocessed milkvetch root, 13 to 19 g of heterophylly falsestarwort root, 12 to 16 g of poria from Yunnan of China, 15 to 19 g of radix paeoniae alba from Hangzhou of China, 14 to 18 g of rehmannia root, 18 to 23 g of polygonatum, 12 to 17 g of light bamboo shavings, 8 to 12 g of unprocessed largehead atractylodes rhizome, 10 to 14 g of small liquorice, 7 to 12 g of radix angelicae sineinsis, 9 to 14 g of radix achyranthis bidentatae, 25 to 30 g of radix achyranthis bidentatae, 25 to 30 g of lalang grass rhizome, 10 to 15 g of chicken's gizzard-membrane, 28 to 35 g of hematite powder and 28 to 32 of saute mulberry twig. The method for preparing the medicine of the present invention has the following steps: the raw materials are weighed according to the proportion by weight at first; successively, the raw materials are ground into fine powder of 200 meshes; then, the raw materials are uniformly mixed and encapsulated.
Description
Technical field
The present invention relates to a kind of medicine of prevention of stroke disease, it belongs to a kind of is the Chinese patent medicine that raw material is made by Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
Apoplexy (hemiplegia) be a kind of in, be easy to get old age, the disease easily violated, the disability rate of this disease and mortality rate are all very high.And the medicine for the treatment of apoplexy at present is divided into two classes, and a class is Chinese patent medicines such as HUATUO ZAIZAO WAN, XIAOSHUANTONG; Another kind of is Western medicine such as beniol injection.These medicines bias toward the treatment after disease takes place.Though they can rescue patient return from the verge of death, all make the patient stay the deformity that is difficult to cure.Therefore these medicines exist difficult points such as control is untimely, medical expense height.
Summary of the invention
The objective of the invention is to solve that the control that the medicine of existing treatment apoplexy disease exists is untimely, medical expense high-technology difficult point and provide a kind of and can the prevention of stroke disease take place and the medicine of the prevention of stroke disease that expense is low.
Another object of the present invention provides the preparation method of this medicine.
Medicine of the present invention is the medicament of being made by the following weight proportion raw material:
Radix Astragali 12-18 gram Radix Pseudostellariae 13-19 gram PORIA from Yunnan of China 12-16 gram
Radix Paeoniae Alba 15-19 gram Radix Rehmanniae 14-18 gram Rhizoma Polygonati Odorati 18-23 gram
Phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eats 12-17 gram Rhizoma Atractylodis Macrocephalae 8-12 and restrains little Radix Glycyrrhizae 10-14 gram
Radix Angelicae Sinensis 7-12 gram Radix Achyranthis Bidentatae 9-14 gram Rhizoma Imperatae 25-30 gram
Endothelium Corneum Gigeriae Galli 10-15 gram Haematitum powder 28-35 gram is fried Ramulus Mori 28 32 grams.
The optimum weight proportioning of medicine of the present invention is:
Radix Astragali 15 gram Radix Pseudostellariaes 15 gram PORIA from Yunnan of China 15 gram Radix Paeoniae Alba 15 grams
Radix Rehmanniae 15 gram Rhizoma Polygonati Odorati 20 gram phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendles eat 15 gram Rhizoma Atractylodis Macrocephalae, 10 grams
Little Radix Glycyrrhizae 10 gram Radix Angelicae Sinensis 10 gram Radix Achyranthis Bidentataes 10 gram Rhizoma Imperataes 30 grams
Endothelium Corneum Gigeriae Galli 15 gram Haematitum powder 30 grams are fried Ramulus Mori 30 grams.
The medicament of medicine of the present invention is a kind of in capsule or the loose powder agent.
The method for preparing medicine of the present invention is: at first by above-mentioned weight proportion take by weighing that Radix Astragali, Radix Pseudostellariae, PORIA from Yunnan of China, Radix Paeoniae Alba, Radix Rehmanniae, Rhizoma Polygonati Odorati, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle are eaten, Rhizoma Atractylodis Macrocephalae, little Radix Glycyrrhizae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Imperatae, Endothelium Corneum Gigeriae Galli, Haematitum powder and fry the Ramulus Mori raw material, then above-mentioned raw materials is ground into 200 purpose fine powders, during mix homogeneously incapsulates then.
It is that monarch drug is with benefiting qi and nourishing blood that medicine of the present invention adopts Radix Pseudostellariae, the Radix Astragali and Rhizoma Polygonati Odorati; Adopting Radix Angelicae Sinensis, the Radix Paeoniae Alba, little Radix Glycyrrhizae and Radix Rehmanniae is that ministerial drug is with heat clearing and blood cooling; Adopting Rhizoma Imperatae and frying Ramulus Mori is that adjuvant drug is controlled contracture with blood stasis dispelling removing heat from blood, the meridian dredging that reduces phlegm, dispels the wind; Adopt Endothelium Corneum Gigeriae Galli, Haematitum powder, Radix Achyranthis Bidentatae and phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eat into messenger drug with suppressing the hyperactive liver town gas, sperm adding and marrow healthing and soothing liver-QI for relieving depression.Therefore, compare with background technology, the present invention has that the prevention of stroke disease takes place and advantage such as expense is low.Through 860 patients that the apoplexy symptom is arranged are carried out clinical trial, total effective rate is 95.8%, and its effect is very remarkable.
The specific embodiment
Embodiment 1
Take by weighing raw material by following weight proportion:
15 kilograms of Radix Astragali, 15 kilograms of Radix Pseudostellariaes, 15 kilograms of PORIA from Yunnan of China, 15 kilograms of Radix Paeoniae Alba, 15 kilograms of Radix Rehmanniae, 20 kilograms of Rhizoma Polygonati Odorati, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eat 15 kilograms, 10 kilograms of Rhizoma Atractylodis Macrocephalae, 10 kilograms in little Radix Glycyrrhizae, 10 kilograms of Radix Angelicae Sinensis, 10 kilograms of Radix Achyranthis Bidentataes, 30 kilograms of Rhizoma Imperataes, 15 kilograms of Endothelium Corneum Gigeriae Galli, 30 kilograms in Haematitum powder, fry 30 kilograms of Ramulus Moris.
Production method is as follows:
At first above-mentioned raw materials is ground into 200 purpose fine powders, during mix homogeneously incapsulates then.Powder charge 0.3 gram in each capsule.
Using method: every day three times, each 4.
Embodiment 2
Take by weighing raw material by following weight proportion:
12 kilograms of Radix Astragali, 13 kilograms of Radix Pseudostellariaes, 12 kilograms of PORIA from Yunnan of China, 17 kilograms of Radix Paeoniae Alba, 14 kilograms of Radix Rehmanniae, 18 kilograms of Rhizoma Polygonati Odorati, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eat 12 kilograms, 8 kilograms of Rhizoma Atractylodis Macrocephalae, 12 kilograms in little Radix Glycyrrhizae, 7 kilograms of Radix Angelicae Sinensis, 9 kilograms of Radix Achyranthis Bidentataes, 25 kilograms of Rhizoma Imperataes, 10 kilograms of Endothelium Corneum Gigeriae Galli, 28 kilograms in Haematitum powder, fry 28 kilograms of Ramulus Moris.
Production method is identical with embodiment's 1.Powder charge 0.4 gram in each capsule.
Embodiment 3
Take by weighing raw material by following weight proportion:
18 kilograms of Radix Astragali, 19 kilograms of Radix Pseudostellariaes, 16 kilograms of PORIA from Yunnan of China, 19 kilograms of Radix Paeoniae Alba, 18 kilograms of Radix Rehmanniae, 23 kilograms of Rhizoma Polygonati Odorati, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eat 17 kilograms, 12 kilograms of Rhizoma Atractylodis Macrocephalae, 14 kilograms in little Radix Glycyrrhizae, 12 kilograms of Radix Angelicae Sinensis, 14 kilograms of Radix Achyranthis Bidentataes, 28 kilograms of Rhizoma Imperataes, 13 kilograms of Endothelium Corneum Gigeriae Galli, 35 kilograms in Haematitum powder, fry 32 kilograms of Ramulus Moris.
Production method is identical with embodiment's 1.Powder charge 0.5 gram in each capsule.
Claims (4)
1, a kind of medicine of prevention of stroke disease is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Astragali 12-18 gram Radix Pseudostellariae 13-19 gram PORIA from Yunnan of China 12-16 gram
Radix Paeoniae Alba 15-19 gram Radix Rehmanniae 14-18 gram Rhizoma Polygonati Odorati 18-23 gram
Phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle eats 12-17 gram Rhizoma Atractylodis Macrocephalae 8-12 and restrains little Radix Glycyrrhizae 10-14 gram
Radix Angelicae Sinensis 7-12 gram Radix Achyranthis Bidentatae 9-14 gram Rhizoma Imperatae 25-30 gram
Endothelium Corneum Gigeriae Galli 10-15 gram Haematitum powder 28-35 gram is fried Ramulus Mori 28-32 gram.
2, the medicine of a kind of prevention of stroke disease according to claim 1, wherein the weight proportion of each raw material is:
Radix Astragali 15 gram Radix Pseudostellariaes 15 gram PORIA from Yunnan of China 15 gram Radix Paeoniae Alba 15 grams
Radix Rehmanniae 15 gram Rhizoma Polygonati Odorati 20 gram phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendles eat 15 gram Rhizoma Atractylodis Macrocephalae, 10 grams
Little Radix Glycyrrhizae 10 gram Radix Angelicae Sinensis 10 gram Radix Achyranthis Bidentataes 10 gram Rhizoma Imperataes 30 grams
Endothelium Corneum Gigeriae Galli 15 gram Haematitum powder 30 grams are fried Ramulus Mori 30 grams.
3, the medicine of a kind of prevention of stroke disease according to claim 1 is characterized in that: described medicament is a kind of in capsule or the loose powder agent.
4, the preparation method of the medicine of the described prevention of stroke disease of claim 3, it is characterized in that it is made up of the following step: take by weighing at first by weight ratio that Radix Astragali, Radix Pseudostellariae, PORIA from Yunnan of China, Radix Paeoniae Alba, Radix Rehmanniae, Rhizoma Polygonati Odorati, phyllostachys nigra (lodd.ex lindl.) munro var.henonis (miff.) spapf et rendle are eaten, Rhizoma Atractylodis Macrocephalae, little Radix Glycyrrhizae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Rhizoma Imperatae, Endothelium Corneum Gigeriae Galli, Haematitum powder and fry the Ramulus Mori raw material, then above-mentioned raw materials is ground into 200 purpose fine powders, during mix homogeneously incapsulates then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012157 CN1272060C (en) | 2004-02-27 | 2004-02-27 | Medicine for preventing apoplexy and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410012157 CN1272060C (en) | 2004-02-27 | 2004-02-27 | Medicine for preventing apoplexy and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1559499A CN1559499A (en) | 2005-01-05 |
| CN1272060C true CN1272060C (en) | 2006-08-30 |
Family
ID=34440026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410012157 Expired - Fee Related CN1272060C (en) | 2004-02-27 | 2004-02-27 | Medicine for preventing apoplexy and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1272060C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108096479A (en) * | 2017-12-14 | 2018-06-01 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of pre- anti-stroke health products |
-
2004
- 2004-02-27 CN CN 200410012157 patent/CN1272060C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1559499A (en) | 2005-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1272057C (en) | Chinese traditional medicine for treating facial paralysis, facial spasm and trifacial neuralgia | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1272060C (en) | Medicine for preventing apoplexy and its preparation method | |
| CN101112475A (en) | Chinese traditional medicine composition for treating diabetes and the complication | |
| CN1772100A (en) | Medicine for treating psoriasis and its prepn | |
| CN1174078A (en) | Chinese medicine for ischemic necrosis of thighbone head | |
| CN1261149C (en) | Medicine for treating rheumatoid arthritis, femur necrosis and ankylosing spondylitis | |
| CN101317958B (en) | Medicament for treating uarthritis, that is Tongfengning capsule and preparation method thereof | |
| CN1164294C (en) | Liver cancer resisting medicine | |
| CN1086129C (en) | Hepatitis restoration pill | |
| CN1094624A (en) | Quick-acting fat-lowering spirit Chinese medicine | |
| CN1114902A (en) | Lupus powder medicine and its preparation method | |
| CN1156292C (en) | Medicine for curing cholecystitis and its preparing method | |
| CN1199685C (en) | Medicine for treating upper respiratory tract infection type cold | |
| CN1190215C (en) | Chinese medicine for treating rheumatism | |
| CN1048631C (en) | Medicinal pellet or powder for curing osteoporosis | |
| CN1184995C (en) | Kidney-strengthening and pregnancy assisting granule | |
| CN1128627C (en) | Rheumatism treating oral capsule and plaster and their preparation method | |
| CN1244370C (en) | Medicinal composition for curing skin disease | |
| CN1054986C (en) | Chinese medicine pill for treating rheumatoid disease | |
| CN1036503C (en) | Medicine for treating systemic lupus erythematosus and producing method thereof | |
| CN1161135C (en) | Medicine for curing carcinoma of stomach | |
| CN101032573A (en) | Medicine for treating psoriasis and its preparing process | |
| CN1876082A (en) | A Chinese medicine for treating femoral head necrosis and preparation method thereof | |
| CN1167433C (en) | Medicine for treating acne and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060830 |